Synergistic effects of PARP inhibitors by Schlafen 11 and BRCA2-deficiency through accumulation of single-strand DNA gaps behind a fork
Hiroshi Onji(Ehime University), Junko Murai(National Institutes of Health)
Cited by 1
Related Papers
Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
|Oncotarget|2016|292
SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis
|Molecular Cell|2025|25
The crucial role of single-stranded DNA binding in enhancing sensitivity to DNA-damaging agents for Schlafen 11 and Schlafen 13
|iScience|2023|16